Table I.
Clinical characteristics of the patients.
| Clinical characteristics of the patients | Patients |
|---|---|
| Enrolment Site – no. (%) | N = 35 |
| Barts Health NHS Trust | 25 (71%) |
| Homerton University Hospital NHS Foundation Trust | 4 (11%) |
| The London Clinic | 3 (9%) |
| Southend University Hospital NHS Foundation Trust | 1 (3%) |
| Barking, Havering and Redbridge University Hospitals NHS Trust | 1 (3%) |
| Basildon and Thurrock University Hospitals NHS Foundation Trust | 1 (3%) |
| Median age (range) – years | 69 (31–87) |
| Sex – no. (%) | N = 35 |
| Male | 23 (66%) |
| Female | 12 (34%) |
| Haemato‐oncological diagnosis – no. (%) | N = 35 |
| Multiple myeloma | 12 (34%) |
| Chronic lymphocytic leukaemia/Small lymphocytic lymphoma | 5 (14%) |
| Diffuse large B cell lymphoma | 4 (11%) |
| Acute lymphoblastic leukaemia | 4 (11%) |
| Follicular lymphoma | 3 (9%) |
| Acute myeloid leukaemia | 2 (6%) |
| Mantle cell lymphoma | 1 (3%) |
| Aplastic anaemia | 1 (3%) |
| Myelofibrosis | 1 (3%) |
| Myelodysplastic syndrome | 1 (3%) |
| Monoclonal gammopathy of undetermined significance | 1 (3%) |
| Pre‐existing hypogammaglobulinaemia | N = 24 |
| Yes | 13 (54%) |
| No | 11 (46%) |
| Number of lines of treatment – no. (%) | N = 35 |
| Untreated | 3 (9%) |
| 1st line treatment | 19 (54%) |
| 2nd line treatment | 8 (23%) |
| ≥3rd line treatment | 5 (14%) |
| Patients on active treatment at time of COVID‐19 diagnosis | N = 35 |
| Yes | 24 (69%) |
| No | 11 (31%) |
| Co‐existing disorders – no. (%) | N = 35 |
| Hypertension | 10 (29%) |
| Renal failure | 5 (14%) |
| Diabetes | 5 (14%) |
| Previous cancer | 4 (11%) |
| Previous venous thromboembolism | 3 (9%) |
| Atrial fibrillation | 3 (9%) |
| Ischaemic heart disease | 2 (6%) |
| Asthma | 2 (6%) |
| Valvular heart disease | 2 (6%) |
| Chronic lung disease/COPD | 2 (6%) |
| Co‐existing non‐haematological cancer | 1 (3%) |
| Hyper‐obstructive cardiomyopathy | 1 (3%) |
| Liver fibrosis | 1 (3%) |
| Symptoms – no. (%) | N = 35 |
| Fever | 27 (77%) |
| Cough | 21 (60%) |
| Shortness of breath | 19 (54%) |
| Weakness | 5 (14%) |
| Myalgia | 4 (11%) |
| Diarrhoea | 3 (6%) |
| Coryza | 2 (6%) |
| Chest pain | 2 (6%) |
| Headache | 1 (3%) |
| Vasovagal episode | 1 (3%) |
| Anosmia | 1 (3%) |